BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37823774)

  • 1. Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells.
    Visser LL; Bleijs M; Margaritis T; van de Wetering M; Holstege FCP; Clevers H
    Cancer Res Commun; 2023 Oct; 3(10):2158-2169. PubMed ID: 37823774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing Sarcoma.
    Jain K; Henrich IC; Quick L; Young R; Mondal S; Oliveira AM; Blobel GA; Chou MM
    Cancer Res Commun; 2023 Aug; 3(8):1615-1627. PubMed ID: 37615015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-Specific Protease 6 Functions as a Tumor Suppressor in Ewing Sarcoma through Immune Activation.
    Henrich IC; Jain K; Young R; Quick L; Lindsay JM; Park DH; Oliveira AM; Blobel GA; Chou MM
    Cancer Res; 2021 Apr; 81(8):2171-2183. PubMed ID: 33558334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy.
    Sand LG; Berghuis D; Szuhai K; Hogendoorn PC
    Cancer Immunol Immunother; 2016 Aug; 65(8):995-1002. PubMed ID: 27369431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immunotherapy strategies for Ewing sarcoma.
    Rossig C
    Immunotherapy; 2014; 6(5):611-21. PubMed ID: 24896629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the tumor microenvironment of Ewing sarcoma.
    Morales E; Olson M; Iglesias F; Luetkens T; Atanackovic D
    Immunotherapy; 2021 Dec; 13(17):1439-1451. PubMed ID: 34670399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
    Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting.
    Kailayangiri S; Altvater B; Meltzer J; Pscherer S; Luecke A; Dierkes C; Titze U; Leuchte K; Landmeier S; Hotfilder M; Dirksen U; Hardes J; Gosheger G; Juergens H; Rossig C
    Br J Cancer; 2012 Mar; 106(6):1123-33. PubMed ID: 22374462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target.
    Town J; Pais H; Harrison S; Stead LF; Bataille C; Bunjobpol W; Zhang J; Rabbitts TH
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3603-8. PubMed ID: 26979953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
    Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
    Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma.
    Maurer LM; Daley JD; Mukherjee E; Venier RE; Julian CM; Bailey NG; Jacobs MF; Kumar-Sinha C; Raphael H; Periyapatna N; Weiss K; Janeway KA; Mody R; Lucas PC; McAllister-Lucas LM; Bailey KM
    Cancer Res Commun; 2022 Apr; 2(4):220-232. PubMed ID: 36187937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel t(4;22)(q31;q12) produces an EWSR1-SMARCA5 fusion in extraskeletal Ewing sarcoma/primitive neuroectodermal tumor.
    Sumegi J; Nishio J; Nelson M; Frayer RW; Perry D; Bridge JA
    Mod Pathol; 2011 Mar; 24(3):333-42. PubMed ID: 21113140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.
    Berghuis D; Santos SJ; Baelde HJ; Taminiau AH; Egeler RM; Schilham MW; Hogendoorn PC; Lankester AC
    J Pathol; 2011 Feb; 223(3):347-57. PubMed ID: 21171080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immunotherapy in Ewing sarcoma.
    Morales E; Olson M; Iglesias F; Dahiya S; Luetkens T; Atanackovic D
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33293354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.
    Roundhill EA; Chicon-Bosch M; Jeys L; Parry M; Rankin KS; Droop A; Burchill SA
    Cell Oncol (Dordr); 2021 Oct; 44(5):1065-1085. PubMed ID: 34403115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primitive neuroectodermal tumor/Ewing sarcoma of the retina.
    Grossniklaus HE; Shehata B; Sorensen P; Bergstrom C; Hubbard GB
    Arch Pathol Lab Med; 2012 Jul; 136(7):829-31. PubMed ID: 22742557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison and analysis of different dendritic cell-based immunotherapeutic strategies for Ewing sarcoma: in vitro and in vivo induction on SCID mouse models].
    Zhao H; Tang S; Qu HY; Guo W; Li X; Peng CL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 39(4):403-8. PubMed ID: 17657269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are EWSR1-FLI-positive cell lines from patients with other diagnoses than Ewing sarcoma really Ewing sarcoma cell lines?
    Staege MS
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27769. PubMed ID: 31006967
    [No Abstract]   [Full Text] [Related]  

  • 19. Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and Function.
    Gassmann H; Schneider K; Evdokimova V; Ruzanov P; Schober SJ; Xue B; von Heyking K; Thiede M; Richter GHS; Pfaffl MW; Noessner E; Stein LD; Sorensen PH; Burdach SEG; Thiel U
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of myeloid signature genes for predicting prognosis and immune landscape in Ewing sarcoma.
    Zhang Z; Shi Y; Zhu Z; Fu J; Liu D; Liu X; Dang J; Tao H; Fan H
    Cancer Sci; 2023 Apr; 114(4):1240-1255. PubMed ID: 36478349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.